ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
621	Centers for Disease Control and Prevention	Html	en	Test Your Knowledge: Sickle Cell Disease - CDC Features	September is Sickle Cell Disease (SCD) Awareness Month. How much do you know about SCD? Take a quiz to find out and learn about the Centers for Disease Control and Prevention’s (CDC’s) work.	CDC.gov Current Features 0.906892	specific topic 0.706916	CLICK HERE
688	Centers for Disease Control and Prevention	Html	en	How We Can Protect Our Children From Secondhand Smoke - Smoking & Tobacco Use	These brochures will educate those who care for children on the health dangers of secondhand smoke (SHS). The goal is to deliver culturally relevant information to various populations that will motivate them to reduce SHS exposure to children by making their homes and cars smoke-free.	SHS exposure 0.82993 various populations 0.584061 children 0.234383	health dangers 0.638095 secondhand smoke 0.689255	CLICK HERE
5277	Centers for Disease Control and Prevention	Html	en	Half of All States Have Smoke-Free Worksites, Restaurants and Bars: April 21, 2011	Half of All States Have Smoke-Free Worksites, Restaurants and Bars	CDC director Thomas 0.330091 smoke-free status 0.304831 Mortality Weekly Report 0.323907 smoke-free laws 0.790048 statewide smoking restrictions 0.349519 secondhand smoke exposure 0.976888 tobacco smoke—including secondhand 0.411767 comprehensive smoke-free laws 0.735041 health care costs 0.290728	states 0.224496 lung cancer deaths 0.280295 Chronic Disease Prevention 0.271206 private sector worksites 0.414848 State Tobacco Activities 0.26325 local smoke-free laws 0.438459 CDC report 0.219353 heart disease deaths 0.284194	CLICK HERE
5776	Centers for Disease Control and Prevention	Html	en	Vinyl bromide - NIOSH Pocket Guide to Chemical Hazards	null	MPEG 0.378858 search 0.263099 PDF 0.261307 PPT 0.446092	DOC 0.368812 information 0.262482 different file formats 0.938484 page 0.276773	CLICK HERE
11840	Centers for Disease Control and Prevention	Html	en	Public Health Research on Fragile X Syndrome	The Centers for Disease Control and Prevention works with fragile X syndrome (FXS) clinicians and researchers to build a data resource to help answer important clinical care and public health research questions about this condition.	Fragile X Clinical 0.466225 partial data 0.466027 CDC 0.487658 FXS patient advocate 0.760005 individuals 0.510986 Disease Control 0.49545 mutation FXS 0.794531 broader research community 0.489403 autism spectrum disorder 0.47386 health research questions 0.581161 health professionals 0.497143 research community 0.49177 important clinical care 0.503043 fragile X specialty 0.464501 researchers 0.493101 Global Developmental Delays 0.474128 broader FXS research 0.796956 early identification 0.521616 FXS data collection 0.822518 FXS research 0.823707 FXS clinicians 0.767264 FXS patients 0.730345 intellectual disability 0.541428 FXS 0.999082 fragile X syndrome 0.506446	complex health challenges 0.507511 FXS population 0.865677 multiple data points 0.509787 co-occurring conditions 0.500318 FXS stakeholders 0.751969 Accessible Research Database 0.498503 follow-up longitudinal data 0.507097 FXS clinical care 0.762426 sensory integration issues 0.498363 public health knowledge 0.566889 CDC funds 0.468318 healthcare professionals 0.55291 public health 0.667008 latest FXS 0.75082 FXS referral 0.739239 future research efforts 0.488088 fragile X-associated disorders 0.498556 data resource 0.476833 CDC researchers 0.468473 families 0.498014 complete baseline data 0.507249 better understanding FXS 0.808932 public health data 0.540126 allied health professionals 0.497019	CLICK HERE
11850	Centers for Disease Control and Prevention	Html	en	Pertussis | Whooping Cough | Clinical | Disease Specifics | CDC	Pertussis: Disease Specifics	1940s 0.320892 CDC 0.346566 bacteria 0.336238 United States 0.409982 pre-vaccine era 0.401408 alveolar macrophages 0.406636 acute infectious disease 0.499315 respiratory epithelial cells 0.472417 Page 0.317276 Research 0.316979 B. pertussis 0.723725 pertussis 0.994496 number 0.318046 20th century 0.409018 genetic level 0.39646 immune response 0.393884 inflammation 0.31952 produces immunity 0.398704 underway 0.321933 childhood mortality 0.413698 recent changes 0.392089 toxin-mediated disease 0.38966	observational studies 0.391402 cases 0.380789 biologically active products 0.470419 tissues 0.31889 pertussis infection 0.625866 bacterium Bordetella pertussis 0.817731 gram-negative bacterium 0.410527 isolation 0.317782 peak 0.317224 major cause 0.408439 increase 0.366794 public health experts 0.488558 recent studies 0.385168 respiratory tract 0.393703 toxins 0.31871 common childhood diseases 0.501716 special media 0.394341 pertussis vaccine 0.672913 cilia 0.349904 incidence 0.320313 clinical features 0.392508	CLICK HERE
12337	Centers for Disease Control and Prevention	Html	en	Prompt Use of Antivirals is Key this Flu Season | CDC Features	Influenza activity in the United States is high overall and is likely to continue for weeks. Influenza A (H3N2) viruses have been most common, and the majority of H3N2 viruses analyzed this season are different from the H3N2 viruses in this season's flu vaccine. This may reduce how well the vaccine protects against those H3N2 viruses.	Influenza activity 0.542211 CDC 0.438556 Mortality Weekly Report 0.429669 health care provider 0.486967 randomized controlled trials 0.496481 flu treatment 0.507893 influenza antiviral medications 0.910237 influenza confirmatory testing 0.513985 high risk patients 0.422229 patients 0.435084 flu illness 0.574728 flu antiviral drugs 0.871297 flu antivirals 0.525104 anti-influenza drugs 0.400719 antiviral recommendations 0.568669 annual influenza vaccination 0.514492 15th press release 0.428583 available influenza 0.464041 high risk 0.460142 important background information 0.408204 Antiviral treatment 0.511139 Antiviral influenza 0.637555 vaccine production 0.387788 severe flu illness 0.557424	flu vaccine 0.758224 milder illness 0.375493 flu complications 0.51987 percent 0.37989 annual flu vaccine 0.594621 high-risk patients 0.375013 CDC qualitative research 0.42622 vaccine virus 0.383999 positive flu test 0.561895 vaccine viruses 0.393156 public health benefit 0.409877 low clinician awareness 0.416214 current flu season 0.579193 percent effectiveness 0.379853 antiviral drugs 0.950849 influenza antiviral drug 0.646549 past influenza seasons 0.511414 flu viruses 0.544853 people 0.384503 treatment efforts 0.378793 seasonal influenza illness 0.548105 influenza viruses 0.482232 CDC Health Update 0.433204 severe illness 0.373511	CLICK HERE
13246	Centers for Disease Control and Prevention	Html	en	CDC Community Health Improvement Navigator | CDC Features	Invest in Your Community: Improve Health and Well-Being for All	stakeholders expert-vetted tools 0.402206 IRS Final Rule 0.544794 Service Final Rule 0.35147 online CHI Navigator 0.477816 community stakeholders 0.405849 Health Needs Assessments 0.72902 Collaborative CHI section 0.418676 collaborative CHI process 0.370967 targeted tools 0.240755 Disease Control 0.241905 brief vignettes highlight 0.355698 health behaviors 0.301336 health systems 0.618767 high-priority actions 0.245559 population health 0.296303 greater impact 0.357925 Asked Questions section 0.359929 economic vitality 0.243892 Excise Tax Return 0.319892 community health 0.916758 adequate nutrition—and 0.228738 relevant quotations 0.230905 public health agencies 0.632349 Community Health Needs 0.720483	community health systems 0.451256 collaborative CHI work 0.414127 Charitable Hospitals 0.573209 Key target audiences 0.33202 fact sheets 0.234992 patient outcomes 0.228389 action areas 0.359102 Interventions section 0.277073 potential partners 0.237492 health departments 0.304765 health care 0.588331 community organizations 0.281314 community partners 0.282665 clinical care 0.232919 Review information 0.234377 CHI Efforts section 0.410008 CHI process 0.438213 CHI Navigator 0.93956 collaborative chi 0.449364 community health assessment 0.466575 health care sector 0.417083 sustainable financial model 0.328748 greatest impact 0.237523 Community health improvement 0.516138	CLICK HERE
13491	Centers for Disease Control and Prevention	Html	en	Use and Interpretation of a Rapid Respiratory SyncytialVirus Antigen Detection Test Among Infants Hospitalized in aNeonatal Intensive Care Unit - Wisconsin, March 2015	Lina I. Elbadawi, MD1,2; Thomas Haupt, MS2; Erik Reisdorf, MPH3; Tonya Danz3; Jeffrey P. Davis, MD2.	positive predictive value 0.546499 real-time polymerase chain 0.531364 asymptomatic neonate 0.642831 real-time PCR 0.446498 RSV infection 0.769413 nasopharyngeal specimens 0.792925 asymptomatic infants 0.539351 viral transport media 0.50641 hospital laboratory 0.654979 peak RSV season 0.862936 negative test 0.435115 Jeffrey P. Davis 0.552996 infant nasopharyngeal specimens 0.705975 nasopharyngeal swab 0.990039 neonate whose RRADT 0.563897 asymptomatic NICU patients 0.68081 Wisconsin State Laboratory 0.54342 Erik Reisdorf 0.437358 reported PPV 0.481282 infection outbreak 0.456059 3Wisconsin State Laboratory 0.518061 widespread RSV infection 0.724861 different hospital room 0.541306 respiratory syncytial virus 0.571763	hospital laboratory RRADT 0.549038 asymptomatic patients 0.52657 1Epidemic Intelligence Service 0.510778 Public Health 0.66128 multiplex respiratory virus 0.537819 personal identifying information 0.501107 Wisconsin Division 0.538689 symptomatic neonates 0.476912 characteristic clinical illness 0.508118 index patient 0.437827 test result interpretation 0.535494 neonatal intensive care 0.550645 positive test 0.471461 nasopharyngeal swab specimen 0.964632 asymptomatic neonates 0.606225 positive RRADT results 0.579352 RSV antigen detection 0.718158 Tonya Danz 0.448809 RSV subgroups 0.593028 Sixteen nasopharyngeal specimens 0.748663 RSV infection prevalence 0.688686 RRADT manufacturer 0.444062 Lina I. Elbadawi 0.772056 nasopharyngeal swab specimens 0.952664	CLICK HERE
15568	Centers for Disease Control and Prevention	Html	en	Childhood, Adolescent and Catchup Immunization Schedules	CDC official immunization schedules for children, preteens, teens, and adults for health care professionals, parents, and the general public.	meningococcal B vaccine 0.535001 Adolescent immunization schedule 0.611594 hepatitis B status 0.483375 immunization catch-up schedule 0.729365 HBsAg-positive mothers 0.484527 immunization schedule 0.96948 United States 0.567064 routinely recommended vaccines 0.554586 primary vaccination series 0.530333 Hepatitis B vaccination 0.480806 U.S. IPV schedule 0.535687 Display Immunization Schedules 0.572326 Immunization Practices 0.525439 CDC Vaccine Schedules 0.614211 routine poliovirus vaccination 0.533095 catch-up vaccine schedules 0.601267 Hepatitis B vaccine 0.569727 routine vaccination portion 0.521558 meningococcal vaccines footnote 0.607779 pneumococcal conjugate vaccine 0.586763 Childhood Vaccine Quiz 0.558641 vaccine booster dose 0.617462 Display schedule 0.542135	Binational Immunization Resource 0.550867 web page 0.492637 acellular pertussis vaccine 0.70821 childhood/adolescent immunization catch-up 0.699181 child/adolescent immunization schedule 0.643853 latest recommended immunization 0.551985 bivalent HPV vaccine 0.599298 childhood/adolescent immunization schedule 0.630204 vaccine 0.810478 new 2-dose schedule 0.51733 poliovirus vaccination status 0.539149 U.S. vaccination requirements 0.532937 catch-up immunization schedule 0.700391 pneumococcal vaccine footnote 0.665151 adult immunization schedule 0.613152 available vaccine doses 0.649397 HPV vaccination series 0.53994 influenza vaccine footnote 0.67452 immunization schedules 0.617347 human papillomavirus vaccine 0.59117 type b vaccine 0.524494 poliovirus vaccine 0.537823	CLICK HERE